Gene Therapy 2019 Global Market Outlook,Research,Trends and Forecast to 2026

WiseGuyReports.Com Publish a New Market Research Report On –“ Gene Therapy 2019 Global Market Outlook,Research,Trends and Forecast to 2026”.

Pune, India - April 15, 2019 /MarketersMedia/ —

Gene Therapy Industry 2019

Description:-

The global gene therapy market is anticipated to reach USD 4,300 million by 2021. The demand for gene therapy is primarily driven by continuous technological advancements and successful progression of several clinical trials targeting treatments with strong unmet need. Moreover, rising R&D spend on platform technologies by large and emerging biopharmaceutical companies and favorable regulatory environment will accelerate the clinical development and the commercial approval of gene therapies in the foreseeable future. Despite promise, the high cost of gene therapy represents a significant challenge for commercial adoption in the forecast period.

Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3695595-the-future-of-global-gene-therapy-market-to

For more information or any query mail at sales@wiseguyreports.com

Gene therapy involves inactivating a mutated gene that is not functioning properly and introducing a new gene to assist in fighting a disease. Overall, the field of gene therapy continues to mature and advance with many products in development and nearing commercialization. For instance, Spark Therapeutics received approval of Luxturna, a rare form inherited blindness in December 2017. Gene therapy market in late 2017 also witnessed the approvals of Gilead/Kite Pharma’s Yescarta and Novartis’ Kymriah in the cancer therapeutic area.

Gene therapy offers promise in the treatment of range of indications in cancer and genetic disorders. Large Pharmaceuticals and Biotechnology companies’ exhibit strong interest in this field and key among them include Allergan, Shire, Biomarin, Pfizer and GSK. The gene therapy space is witnessing a wave of partnerships and alliances. Pfizer has recently expanded its presence in gene therapy with the acquisition of Bamboo Therapeutics and Allergan entered the field, with the acquisition of RetroSense and its Phase I/II optogenetic program.

North America holds a dominating position in the global gene therapy market which is followed by Europe and the Asia Pacific. The U.S. has maximum number of clinical trials ongoing followed by Europe. Moreover, the field of gene therapy in the U.S. and Europe continues to gain investor attention driven by success of high visible clinical programs and the potential of gene therapy to address strong unmet need with meaningful commercial opportunity. Moreover, the increasing partnerships and alliances and the disruptive potential of gene therapy bodes well for the sector through the forecast period.
Key Findings from the study suggest products accessible in the market are much competitive and manufacturers are progressively concentrating on advancements to pick up an aggressive edge. Companies are in a stage of development of new items in order to guarantee simple implementation and connection with the current gene. The hospatility segment is anticipated to grow at a high growth rate over the forecast period with the expanding utilization of smart locks inferable from expanding security-related worries among clients amid their stay at the hotels. North America is presumed to dominate the global smart locks market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/3695595-the-future-of-global-gene-therapy-market-to

Table Of Contents – Major Key Points

1. Gene Therapy Overview
1.1. History and Evolution of Gene Therapies
1.2. What is Gene Therapy
1.3. Types of Gene Therapy
1.4. Ex vivo and in vivo Approaches of Gene Therapy
1.5. RNAi Therapeutics
1.6. CAR-T Technology based Gene Therapy
1.7. Types of Vectors used for Gene Therapy
1.7.1. Viral
1.7.2. Non-Viral

2. Historical Marketed Gene Therapies [2003-2012]
2.1. Rexin-G (Epeius Biotechnologies Corporation)
2.2. Gendicine (SiBiono GeneTech Co., Ltd)
2.3. Neovasculgen [Human Stem Cells Institute (HSCI))
2.4. Glybera (UniQure Biopharma B.V.)

3. First Countries to get an access to Gene Therapies
3.1. Philippines for Rexin-G [2003]
3.2. China for Gendicine [2003]
3.3. Russia for Neovasculgen [2011]
3.4. Selected European Countries for Glybera [2012]

4. Marketed Gene Therapies [Approved in Recent Years]
4.1. KYMRIAH (tisagenlecleucel)
4.1.1. Therapy Description
4.1.2. Therapy Profile
4.1.2.1. Company
4.1.2.2. Approval Date
4.1.2.3. Mechanism of Action
4.1.2.4. Researched Indication
4.1.2.5. Vector Used
4.1.2.6. Vector Type
4.1.2.7. Technology
4.1.2.8. Others Development Activities
4.1.3. KYMRIAH Revenue Forecasted till 2021
4.2. YESCARTA (axicabtagene ciloleucel)
4.2.1. Therapy Description
4.2.2. Therapy Profile
4.2.2.1. Company
4.2.2.2. Approval Date
4.2.2.3. Mechanism of Action
4.2.2.4. Researched Indication
4.2.2.5. Vector Used
4.2.2.6. Vector Type
4.2.2.7. Technology
4.2.2.8. Others Development Activities
4.2.3. YESCARTA Revenue Forecasted till 2021
4.3. LUXTURNA (voretigene neparvovec-rzyl)
4.3.1. Therapy Description
4.3.2. Therapy Profile
4.3.2.1. Company
4.3.2.2. Approval Date
4.3.2.3. Mechanism of Action
4.3.2.4. Researched Indication
4.3.2.5. Vector Used
4.3.2.6. Vector Type
4.3.2.7. Technology
4.3.2.8. Others Development Activities
4.3.3. LUXTURNA Revenue Forecasted till 2021
4.4. STRIMVELIS
4.4.1. Therapy Description
4.4.2. Therapy Profile
4.4.2.1. Company
4.4.2.2. Approval Date
4.4.2.3. Mechanism of Action
4.4.2.4. Researched Indication
4.4.2.5. Vector Used
4.4.2.6. Vector Type
4.4.2.7. Technology
4.4.2.8. Others Development Activities
4.4.3. STRIMVELIS Revenue Forecasted till 2021

5. Comparison of current Regulatory Status for Gene Therapy Products
5.1. U.S
5.2. Europe
5.3. Japan

6. Emerging Gene Therapies [Phase III]
6.1. Gene Based Therapeutics under Development
6.2. Therapy Description

7. Indication of Focus in Gene Therapy
7.1. Cancer
7.2. Neurodegenerative Disorders
7.3. Lysosomal Storage Disorders (LSDs)
7.4. Ocular Diseases
7.5. Muscle Disorders
7.6. Anemia
7.7. Hemophilia
7.8. Severe Combined Immunodeficiency due to Adenosine Deaminase deficiency

Continued……

Buy 1-user PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3695595

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuy Research Consultant Pvt Ltd.
Address: Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.
Phone: +1-646-845-9349
Website: https://www.wiseguyreports.com

Source URL: https://marketersmedia.com/gene-therapy-2019-global-market-outlookresearchtrends-and-forecast-to-2026/502768

Source: MarketersMedia

Release ID: 502768

More News From digitalpressnetwork.com

Donors suspend funds for Poland's Jewish museum

Jul 16, 2019

WARSAW, Poland — A Jewish association says some private donors to Poland's renowned Jewish history museum have suspended funding out of concerns about the government's failure to renew the term of its director. A special commission in May approved Dariusz Stola for another five-year term, but Culture Minister Piotr Glinski hasn't yet officially reappointed him. Glinski said recently he was still weighing the decision, because Stola had allegedly refused to make the museum available for a conference that was to be dedicated to the late twin of ruling conservative party leader Jaroslaw Kaczynski. The Museum of the History of Polish...

Moving US land agency west brings praise, prompts questions

Jul 16, 2019

DENVER — The Trump administration's plan to move the government's largest land management office from Washington to Colorado evoked a mix of praise, criticism and questions on Tuesday. The Bureau of Land Management scheduled a formal announcement of its plans Tuesday afternoon. A day earlier, delighted Republican lawmakers said the bureau's headquarters would move to Grand Junction, Colorado, and about 300 jobs would be relocated to Colorado, Nevada, Utah and other Western states. The bureau, part of the Interior Department, oversees nearly 388,000 square miles (1 billion square kilometers) of public land, and 99% is in 12 Western states. Those...

Parsons snub, 'Schitt's Creek' love among Emmy surprises

Jul 16, 2019

NEW YORK — Some Emmy Award nominations seemed like a lock: "Game of Thrones" was going to earn a haul . "The Marvelous Mrs. Maisel" would still charm voters. The final goodbye to "Veep" would surely end in nominations. But who would have bet against Jim Parsons? And who thought "Schitt's Creek" would finally get noticed by Emmy voters long after its cameras were turned off? And who thought the powerful "When They See Us," which shined a light on a 30-year-old miscarriage of justice, would be hailed with over a dozen nominations? Some of the snubs and surprises from...

Emails show Iowa official's Tupac fixation before his ouster

Jul 16, 2019

IOWA CITY, Iowa — The director of Iowa's social services agency was a huge fan of the late rapper Tupac Shakur, and he frequently let his subordinates know it. Emails obtained by The Associated Press show that Iowa Department of Human Services Director Jerry Foxhoven routinely sent messages to employees lauding Shakur's music and lyrics even after at least one complained to lawmakers. Then last month, he sent another such email to all 4,300 agency employees. He was abruptly ousted from his job the next work day. Foxhoven, 66, told employees that he had been a huge fan of the...

Jeffrey Epstein accuser urges more women to speak out

Jul 16, 2019

NEW YORK — One of Jeffrey Epstein's accusers urged other women Tuesday to come forward with allegations against the wealthy financier as federal authorities prosecute him on sex charges. Courtney Wild told reporters at a news conference in New York that Epstein "will never stop sexually abusing children until he is in jail." "We will not get justice until you speak out," Wild said, addressing anyone who believes they have been abused by Epstein. "You are not alone, and this was not your fault." Wild's remarks came a day after she appeared in Manhattan federal court and urged a judge...

Weather, 20 December
Houston Weather
+7

High: +11° Low: -2°

Humidity: 83%

Wind: NNE - 7 KPH

Canberra Weather
+27

High: +27° Low: +17°

Humidity: 87%

Wind: W - 20 KPH

Roissy-en-France Weather
+6

High: +6° Low: -5°

Humidity: 87%

Wind: ENE - 7 KPH

Florence Weather
+9

High: +9° Low: +6°

Humidity: 97%

Wind: ENE - 17 KPH

Parga Weather
+7

High: +16° Low: +4°

Humidity: 100%

Wind: SE - 25 KPH